Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Edwards Lifesciences Corporation ("Edwards" or the "Company") (NYSE: EW) and reminds investors ...

根据 InvestingPro 指标显示，Edwards Lifesciences Corp (NYSE:EW)是一家财务状况良好的419亿美元市值的医疗设备公司。该公司企业战略和企业发展副总裁Donald E. Bobo Jr.最近出售了5,000股公司普通股。这些股票以71.7501美元的加权平均价格售出，交易总额为358,750美元。此次交易是根据预先制定的10b5-1交易计划执行的。

NYSE:EW) Shareholders that lost money on Edwards Lifesciences Corporation(EW) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More ...

The stock's rise snapped a three-day losing streak.

If you are a shareholder who suffered a loss, click here to participate.

Citi raised the firm’s price target on Edwards Lifesciences (EW) to $83 from $81 and keeps a Buy rating on the shares as part of a 2025 outlook ...

根据 InvestingPro 分析，市值419亿美元且财务状况良好的医疗设备公司Edwards Lifesciences Corp (NYSE:EW)的首席财务官Scott B. Ullem最近进行了一系列股票交易，这些交易已向美国证券交易委员会备案。12月9日，Ullem以平均每股71.6805美元的价格出售了11,250股Edwards ...

Edwards Lifesciences Corporation (EW), a global leader in patient-focused medical innovations, was founded in 1958 and is ...

This was the stock's third consecutive day of losses.

Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of all purchasers of securities ...

At its investor day conference, Edwards Lifesciences Corp. prognosticated that an expanded indication in transcatheter aortic ...

LOS ANGELES, CA / ACCESSWIRE / December 10, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a ...